IRVAN syndrome

From WikiMD's Food, Medicine & Wellness Encyclopedia

Alternate names[edit | edit source]

Idiopathic retinal vasculitis-aneurysms-neuroretinitis syndrome; Idiopathic retinal-aneurysms-neuroretinitis syndrome

Definition[edit | edit source]

IRVAN syndrome is an acronym for "idiopathic retinal vasculitis-aneurysms-neuroretinitis syndrome," a condition that primarily affects the eyes.

Cause[edit | edit source]

The underlying cause of IRVAN syndrome is currently unknown.

Inheritance[edit | edit source]

Most cases occur sporadically in people with no family history of the condition.

Onset[edit | edit source]

Although this condition can occur in people of all ages, it is most commonly diagnosed in the third or fourth decade of life.

Signs and symptoms[edit | edit source]

The severity of the condition varies from person to person with some affected people experiencing a mild form that resolves on its own and others experiencing a severe form that may progress to vitreous hemorrhage (leakage of blood into the eye), vision loss and/or glaucoma.

Clinical presentation[edit | edit source]

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.

30%-79% of people have these symptoms

  • Ocular hypertension(High eye pressure)
  • Reduced visual acuity(Decreased clarity of vision)
  • Vitreous floaters(Eye floaters)

5%-29% of people have these symptoms

Diagnosis[edit | edit source]

The disease has variable clinical presentation, and clinical diagnosis is aided by the help of ophthalmic imaging, such as fundus fluorescein angiography (FFA), preferably by wide-field system and optical coherence tomography (OCT).[1].

Treatment[edit | edit source]

  • Treatment varies based on the severity of the condition and the associated signs and symptoms.
  • In severe cases, surgery or medications such as corticosteroids may be recommended.
  • Early intervention in these patients in the form of prompt laser treatment without waiting for neovascularization to develop is important.
  • Anti-VEGF and infliximab have been used as adjunctive treatment in IRVAN with laser treatment to reduce disease progression. [2].

References[edit | edit source]

  1. Bajgai, P., Katoch, D., Dogra, M. R., & Singh, R. (2017). Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. Clinical ophthalmology (Auckland, N.Z.), 11, 1805–1817. https://doi.org/10.2147/OPTH.S128506
  2. Bajgai, P., Katoch, D., Dogra, M. R., & Singh, R. (2017). Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. Clinical ophthalmology (Auckland, N.Z.), 11, 1805–1817. https://doi.org/10.2147/OPTH.S128506

NIH genetic and rare disease info[edit source]

IRVAN syndrome is a rare disease.


This article is a stub.

Help WikiMD grow by registering to expand it.
Editing is available only to registered and verified users.
About WikiMD: A comprehensive, free health & wellness encyclopedia.

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Deepika vegiraju